title: Development and initial testing of the stroke rapid-treatment readiness tool.
abstract: No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.
authors.affiliation: Questions or comments about this article may be directed to DaiWai M. Olson, PhD RN CCRN, at DaiWai.Olson@UTSouthwestern.edu. He is an Associate Professor of Neurology and Neurotherapeutics at the University of Texas Southwestern Medical Center, Dallas, TX. Margueritte Cox, MS, is a Biostatistician at Duke Clinical Research Institute, Durham, NC. Mark Constable, RN, is a Stroke Coordinater at Duke Clinical Research Institute and Duke University, Durham, NC. Gavin W. Britz, MD, is a Professor of Neurosurgery and the Chairman of Neurosurgery at Methodist Hospital, Houston, TX. Cheryl B. Lin, MD, is a Medical Resident at Duke Clinical Research Institute and Duke University, Durham, NC. Louise O. Zimmer, MPH, is a Clinical Research Coordinator at University of North Carolina at Chapel Hill, Chapel Hill, NC. Gregg C. Fonarow, MD, is a Professor of Medicine and Associate Chief of Cardiology at University of California Los Angeles, Los Angeles, CA. Lee H. Schwamm, MD, is a Professor of Neurology at Harvard University and Vice Chairman of Neurology at Massachusetts General Hospital, Boston, MA. Eric D. Peterson, MD MPH, is a Professor of Medicine at Duke Clinical Research Institute and Duke University, Durham, NC.
authors.forename: DaiWai M
authors.initials: DM
authors.lastname: Olson
authors.forename: Margueritte
authors.initials: M
authors.lastname: Cox
authors.forename: Mark
authors.initials: M
authors.lastname: Constable
authors.forename: Gavin W
authors.initials: GW
authors.lastname: Britz
authors.forename: Cheryl B
authors.initials: CB
authors.lastname: Lin
authors.forename: Louise O
authors.initials: LO
authors.lastname: Zimmer
authors.forename: Gregg C
authors.initials: GC
authors.lastname: Fonarow
authors.forename: Lee H
authors.initials: LH
authors.lastname: Schwamm
authors.forename: Eric D
authors.initials: ED
authors.lastname: Peterson
mesh_terms: D002544:Cerebral Infarction / Q000451:nursing* / Q000628:therapy; D061345:Early Medical Intervention / Q000458:organization & administration*; D017598:Efficiency, Organizational; D019983:Guideline Adherence; D006801:Humans; D007262:Infusions, Intravenous; D010343:Patient Admission; D010348:Patient Care Team / Q000458:organization & administration; D058996:Quality Improvement; D015912:Thrombolytic Therapy / Q000451:nursing*; D013996:Time and Motion Studies; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D057188:Workflow
chemical_list: D010959:Tissue Plasminogen Activator
references.citation: Nurs Crit Care. 2009 Sep-Oct;14(5):222-3
references.pmid: 19706072
references.citation: Curr Opin Neurol. 2012 Feb;25(1):5-10
references.pmid: 22157105
references.citation: Am J Med Qual. 2007 May-Jun;22(3):214-7
references.pmid: 17485563
references.citation: Cerebrovasc Dis. 2005;19(2):96-101
references.pmid: 15608433
references.citation: JAMA. 1998 May 6;279(17):1392-4
references.pmid: 9582048
references.citation: Stroke. 2013 Mar;44(3):870-947
references.pmid: 23370205
references.citation: J Neurosci Nurs. 2011 Dec;43(6):329-36
references.pmid: 22089410
references.citation: Crit Care Nurse. 2012 Apr;32(2):55-64
references.pmid: 22467613
references.citation: Am J Emerg Med. 2011 Jan;29(1):82-5
references.pmid: 20825790
references.citation: J Qual Assur. 1991 Sep-Oct;13(5):8-12
references.pmid: 10112990
references.citation: J Affect Disord. 2010 Oct;126(1-2):155-60
references.pmid: 20466434
references.citation: J Appl Psychol. 2000 Apr;85(2):273-83
references.pmid: 10783543
references.citation: Top Stroke Rehabil. 2002 Autumn;9(3):26-38
references.pmid: 14523706
references.citation: N Engl J Med. 1999 Jun 10;340(23):1781-7
references.pmid: 10362821
references.citation: Stroke. 2011 Oct;42(10):2983-9
references.pmid: 21885841
references.citation: Stroke. 2007 Nov;38(11):3097-115
references.pmid: 17901393
references.citation: Stroke. 2009 Jun;40(6):2079-84
references.pmid: 19372447
references.citation: J Clin Pharm Ther. 2012 Aug;37(4):399-409
references.pmid: 22384796
references.citation: Int J Evid Based Healthc. 2011 Dec;9(4):362-87
references.pmid: 22093387
references.citation: JAMA. 2005 Jul 20;294(3):369-71
references.pmid: 16030283
references.citation: Jt Comm J Qual Patient Saf. 2010 Mar;36(3):133-42
references.pmid: 20235415
references.citation: Crit Care Nurs Clin North Am. 2011 Dec;23(4):661-75
references.pmid: 22118121
references.citation: Crit Pathw Cardiol. 2007 Sep;6(3):91-7
references.pmid: 17804968
references.citation: Jt Comm J Qual Patient Saf. 2005 Jul;31(7):363-71
references.pmid: 16130979
references.citation: Cerebrovasc Dis. 2002;13(4):262-6
references.pmid: 12011551
references.citation: JAMA. 2011 Apr 6;305(13):1288-9
references.pmid: 21467278
references.citation: Stroke. 2006 Jan;37(1):263-6
references.pmid: 16339467
references.citation: Circulation. 2007 May 22;115(20):e478-534
references.pmid: 17515473
references.citation: Aviat Space Environ Med. 2007 May;78(5 Suppl):B58-62
references.pmid: 17547305
references.citation: Qual Manag Health Care. 2002 Fall;11(1):45-54
references.pmid: 12455342
references.citation: J Cardiovasc Nurs. 2007 Jul-Aug;22(4):326-43
references.pmid: 17589286
references.citation: Radiol Manage. 2007 May-Jun;29(3):11-2
references.pmid: 17608290
references.citation: Crit Care Nurs Q. 2009 Jul-Sep;32(3):221-31
references.pmid: 19542973